Top Page
Wilmington
(LSE:WIL)
Wilmington (WIL) vs. iShares MSCI United Kingdom ETF (EWC)
Wilmington Business Overview & Revenue Model
Wilmington Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.49M | 101.49M | 98.32M | 123.50M | 121.03M | 113.03M |
| Gross Profit | 23.85M | 23.85M | 26.56M | 26.36M | 23.78M | 17.64M |
| EBITDA | 24.47M | 24.47M | 29.19M | 25.46M | 45.66M | 8.96M |
| Net Income | 11.56M | 11.56M | 41.21M | 20.20M | 32.83M | -4.55M |
Balance Sheet | ||||||
| Total Assets | 176.99M | 176.99M | 171.65M | 145.70M | 129.76M | 130.34M |
| Cash, Cash Equivalents and Short-Term Investments | 42.24M | 42.24M | 67.52M | 42.17M | 19.79M | 7.37M |
| Total Debt | 1.40M | 1.40M | 2.83M | 7.21M | 7.51M | 34.82M |
| Total Liabilities | 64.25M | 64.25M | 56.34M | 65.06M | 62.67M | 93.67M |
| Stockholders Equity | 112.75M | 112.75M | 115.31M | 80.65M | 67.09M | 36.67M |
Cash Flow | ||||||
| Free Cash Flow | 16.96M | 16.96M | 22.16M | 28.85M | 18.62M | 10.05M |
| Operating Cash Flow | 16.96M | 16.96M | 22.53M | 29.90M | 20.35M | 13.07M |
| Investing Cash Flow | -28.39M | -28.39M | 11.98M | 750.00K | 24.76M | 1.73M |
| Financing Cash Flow | -14.14M | -14.14M | -9.18M | -9.01M | -29.26M | -31.99M |
Wilmington Technical Analysis
Wilmington Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £414.32M | 21.97 | 15.29% | 2.01% | 32.67% | -1.61% | |
66 Neutral | £313.44M | 27.20 | 10.14% | 3.42% | 3.22% | -71.99% | |
64 Neutral | £173.96M | 26.47 | 3.43% | 6.41% | 7.23% | -59.68% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ― | ― | ― | ― | -8.12% | -794.85% | |
60 Neutral | £232.01M | 29.32 | 3.61% | 1.81% | 15.22% | 1.23% | |
57 Neutral | £102.70M | 29.69 | -11.22% | 11.47% | -14.31% | -361.93% |
Wilmington Corporate Events
Wilmington plc announced the granting of nil cost options over 10,397 ordinary shares to Executive Director Guy Millward under the Wilmington Deferred Bonus Plan 2021. This move aligns with the company’s strategy to incentivize its leadership, potentially impacting its operational dynamics and market positioning.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington PLC announced the vesting of nil cost awards and deferred bonuses totaling 357,377 ordinary shares to employees and former employees under the 2017 Performance Share Plan and the 2021 Deferred Bonus Plan. The shares were settled using the company’s treasury shares, with some employees opting to sell shares to cover tax liabilities. This transaction reflects Wilmington’s ongoing commitment to employee compensation and may impact the company’s shareholding structure, as key personnel retain significant shares.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc has announced its updated voting rights and capital structure as of September 30, 2025. The company reports having 90,232,415 ordinary shares in issue, with 572,648 held in treasury, resulting in total voting rights of 89,659,767. This figure is crucial for shareholders to determine their notification obligations regarding changes in their shareholding under the relevant financial regulations.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc has announced the grant of nil cost awards over 560,800 ordinary shares and options with a per share exercise price of £3.35 over 180,949 ordinary shares under its Performance Share Plan 2017. These awards were allocated to employees, including key executives and directors, with vesting contingent on performance conditions assessed over three years and a retention requirement for shares acquired by directors and PDMRs. This move is likely aimed at aligning the interests of management with shareholders and incentivizing performance, which could strengthen Wilmington’s market position and stakeholder confidence.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc announced that its Chair, Gordon Hurst, has purchased 30,000 ordinary shares of the company at an average price of 348.75 pence per share. This transaction increases his total holding to 30,000 shares, representing 0.03% of the company’s issued share capital with voting rights. This move could indicate confidence in the company’s future prospects and may impact investor perceptions positively.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc announced that Gordon Hurst, a non-executive director, purchased 30,000 ordinary shares at an average price of 348.75 pence per share, representing 0.03% of the company’s issued share capital with voting rights. This transaction highlights a potential vote of confidence in the company’s future prospects from its board members, which could positively influence stakeholder perceptions and market positioning.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc reported strong financial performance for the year ended 30 June 2025, with an 11% increase in ongoing revenue to £99.5m and an 18% rise in adjusted profit before tax to £28.4m. The company continued its strategic focus on the GRC markets, enhancing its portfolio through acquisitions such as Phoenix Health & Safety and the proposed acquisition of Conversia, while divesting non-core assets like Compliance Week. These moves are part of Wilmington’s strategy to deepen its expertise in GRC markets and improve the quality of its revenues and profits, positioning the company for further growth.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc has announced that it will release its year-end results for the period ending 30 June 2025 on 22 September 2025. The company will also host an online briefing for analysts and institutional investors, which will be available for later viewing on their website, potentially impacting stakeholder engagement and market perception.
The most recent analyst rating on (GB:WIL) stock is a Buy with a £403.00 price target. To see the full list of analyst forecasts on Wilmington stock, see the GB:WIL Stock Forecast page.
Wilmington plc has announced its proposed acquisition of the Spanish RegTech software business Conversia for €121.6 million. This strategic move aims to enhance Wilmington’s position in the GRC markets, particularly in the Data Privacy sector, by leveraging Conversia’s market-leading status in Spain’s regulatory compliance market. The acquisition is expected to be earnings accretive in the first year and will be financed through a combination of existing cash and new debt facilities. Conversia’s subscription-based revenue model and significant growth potential in the Spanish SME market are seen as key advantages for Wilmington’s expansion strategy.
Wilmington plc has announced that it is in exclusive discussions to potentially acquire Professional Group Conversia S.L.U., amid market speculation. While there is no certainty that an agreement will be reached, if successful, the acquisition would be a significant transaction under UK Listing Rules, potentially impacting Wilmington’s operations and market positioning.
Wilmington plc reported an 11% revenue growth from its ongoing businesses for the year ended 30 June 2025, driven by recent acquisitions in the Health, Safety, and Environment (HSE) sector. Despite challenges in the US healthcare insurance market affecting its events business, the company maintained strong cash conversion and improved profit margins. The acquisition of Phoenix Health & Safety and strategic portfolio management have positioned Wilmington for continued growth, with adjusted profit before tax expected to be £27.7 million.